Usa India city Mumbai experts recommendations Health reports Manufacturing Target Usa India city Mumbai

Sun Pharma acquires 60% stake in Vivaldis Health & Foods for ₹143 cr

Reading now: 486
www.livemint.com

₹143.30 crore from its existing shareholders,  The remaining 40 per cent shareholding will be acquired in future as per certain terms and conditions, said Sun Pharmaceutical in its regulatory filing. “Sun Pharmaceutical Industries Limited (which includes its subsidiaries and/or associate companies) (“Company") has entered into an agreement to acquire 60% shareholding in Vivaldis Health And Foods Private Limited from its existing shareholders with remaining 40% shareholding to be acquired in future as per certain terms & conditions," said the company.

It will be a cash transaction and is expected to be completed by May 2023. “INR 143.30 crores subject to customary closing adjustments for 60% (sixty percent) shareholding," the company said in its filing.

Vivaldis Health & Foods is engaged in the business of trading, distributing, manufacturing and marketing of drugs, food supplements and over the counter products in the companion animal segment of animal healthcare industry.

The revenue for the financial year 2021-22 was ₹29.92 crores. Recently, Sun Pharma's acquisition of Concert adds a complementary derma product to the existing specialty portfolio.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA